Company:  OPGEN INC (OPGN)
Form Type:  PRE 14A
Filing Date:  10/19/2021 
CIK:  0001293818 
Address:  9717 KEY WEST AVENUE
SUITE 100
 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  240-813-1260 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.41  
Change: 
0.03 (2.17%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$54.92M
Trade OPGN now with

© 2021  
Description of Business
Please refer to the Glossary at the end of this Business section for definitions or descriptions of scientific, diagnostic, healthcare, regulatory, and OpGen-specific terms used in this Annual Report. Overview OpGen, Inc. (the "Company") is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. The Company is developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. OpGen's proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections.
Register and access this filing in:     
  FORM PRE 14A
    SPECIAL MEETING OF STOCKHOLDERS
    PROXY STATEMENT
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      BENEFICIAL OWNERS
      NAME AND TITLE
    Certain Relationships and Related Person Transactions
    PROPOSAL NO. ONE - APPROVAL OF AMENDMENT TO THE COMPANY'S ...
    PROPOSAL NO. TWO - APPROVAL OF AMENDMENT TO THE CHARTER TO ...
    PROPOSAL NO. THREE - TO APPROVE THE ADJOURNMENT OF THE ...
    OTHER MATTERS
    STOCKHOLDER PROPOSALS
    PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS